Consistent with our observations in this study, we found that p53-altered mammary tumors demonstrated higher Dbf4 mRNA expression in a series of 201 microarray samples from diverse genetically engineered mouse models (GEMM) of breast cancer [27] (Fig. 7D). The gene discussed is DBF4; the disease is breast cancer.